A longtime leader in healthcare improvement, we’re developing new ways to revolutionize the industry.
Premier weighs in on CMS' proposed payment adjustment for home health and policies on home infusion, value-based care and data collection.
BioSpace | The U.S. Congress typically pins the high cost of healthcare on the pharmaceutical industry, citing sometimes exorbitant prices for disease-modifying therapies. But drug prices are...
While we’ve made some progress, unfortunately, it appears we still have work to do.
PINC AI™ Value-Based Care consulting experts break down all the details for eligible oncology practices and share benefits of participation.
PINC AI™ is narrowing the gaps in maternal and infant care through standardized and timely data.
The Leapfrog Patient Safety Grade are a high priority for any healthcare organization to ensure that the true value of care is illustrated.
One database offers visibility into the maternal and infant relationship to support clinical research and medical solution development that can impact perinatal health.
Premier responds to CMS' proposed policies on the CY 2023 payment update, 340B, N95s and CDS.
We've got four actions CMS can take to help achieve their 2030 goal for accountable care arrangements.
Innovation in data analytics and real-world evidence is helping life sciences companies expedite treatment development and uncover new uses for existing treatments.
MedTech Intelligence | Decentralized trials (DCTs) allow for a novel, agile and more cost-effective approach to an industry standard and traditional methodology.
National Business Journal | Standardized data creates smarter health care and drives innovation and improved outcomes.